Adjuvant Avelumab in Merkel Cell Cancer
This randomized phase III trial studies how well avelumab works in treating patients with
Merkel cell cancer that has spread to the lymph nodes and have undergone surgery and/or
radiation therapy. Immunotherapy with monoclonal antibodies, such as avelumab, may help the
body's immune system attack the cancer, and may interfere with the ability of tumor cells to
grow and spread.